CVRx releases case study on ambulatory hemodynamic changes in HFrEF patients

CVRx releases case study on ambulatory hemodynamic changes in HFrEF patients
CVRx unveils HFrEF case study

CVRx has announced the publication of a new case study aimed at healthcare providers, focusing on ambulatory hemodynamic changes and strategies for diuretic de-escalation in patients with heart failure with reduced ejection fraction (HFrEF).

The study is positioned as an informative resource for clinicians exploring advanced heart failure management and could contribute to evolving best practices in patient care. No details regarding patient outcomes or next steps were disclosed in the announcement.

CVRx previously partnered with Baylor Scott and White Medical Center in Temple, Texas, for their first Barostim implant procedure. The company also collaborated with Florida Medical Clinic Orlando Health to introduce the first Barostim implant at that location, expanding heart failure treatment options in the region. Both initiatives reflect CVRx’s ongoing efforts to support advanced therapies in heart failure management.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.